OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

← Entuk

2023-09-30-accounts

ENTUK

formally known as ENT UK trading as British Academic Conference in Otolaryngology (BACO) and British Association of Otorhinolaryngology - Head and Neck Surgery (BAO-HNS) COMPANY REGISTRATION NUMBER: 06452601 CHARITABLE COMPANY REGISTRATION NUMBER: 1125524

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524 ANNUAL REPORT 2022 - 2023 1 |

After yet another year of health care challenges our NHS struggles on and has never fully recovered following the pandemic of 2020. Whilst the latter posed a significant component, the pandemic cannot take all blame and there has been a fundamental change within the NHS. However, our Association has risen to the challenges and continues to fully support the membership and contribute to developing healthcare strategies for the future.

The jewel in our crown was our highly successful BACO international in February 2023. The success of this event was recognised in the national Association Excellence Awards when we won Silver for 'Best Development of an Existing Association Event' and Bronze for 'Best Longstanding Association Event'. A very special personal thanks to all who contributed to making the event so successful, the ENTUK team and the membership for all of your amazing support. We still have online access to all BACO presentations, freely available to all delegates, and I would urge you to view this incredible educational benefit whilst still available.

We now have BACO 2026 in sight under the strong leadership of Miss Helen Cocks, who will take over as President at the Spring Meeting on 15 April 2024. The Conference is planned to take place in a completely new conference centre in Newcastle in July 2026. We already have an excellent team in place, that includes Miss Kate Blackmore as Project Lead, Mr James O’Hara as Academic Chair, and Mr Ravi Thevasagayam as Industry Lead.

Our Spring Meeting will be held in Edinburgh on Monday 15 April 2024 and will offer an exciting programme for all. This should be a wonderful event and I would urge you to include it in your diaries as a highlight for 2024.

We have been involved in key topics over the year that have included the RCS Census, collaborative work with GIRFT, workforce numbers, NHSE with their e- referral strategy and Outpatient Recovery and Transformation Project, and most importantly, the significant increase in Physician Associates that is planned as a future strategy for the NHS. The latter is an extremely contentious area that many of us feel uncomfortable about. This one area where our place on the Federation of Surgical Specialty Associations (FSSA) and the close interaction with each of the four Surgical Colleges is absolutely crucial. However, we will meet the challenges as they arise, but in the meantime, we will be in a state of sharp awareness and keep you all informed of any significant developments.

Mr Andrew C Swift President of ENTUK

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

2

ENTUK is the professional membership body representing ear, nose and throat surgery, as well as its related specialities, in the United Kingdom. ENTUK supports members at every stage of their careers, from student level through to retirement - a total of some 2,500 medical practitioners.

As well as supporting surgeons and associated medical professionals, ENTUK promotes the understanding of ENT in the media and provides the specialty with a voice. ENTUK is a source of valuable medical information for patients as well as practitioners, and supports research, provides continuing education for specialists, and champions high standards in training. In all our activities we seek to improve the care available to patients suffering from conditions of the ear, nose, throat, head and neck.

Inspiring Excellence and Shaping the Future

This year ENTUK published its exciting new five-year strategy, ‘Inspiring Excellence and Shaping the Future’. This bold and ambitious vision of the Association’s future is built around strategic goals that will enable ENTUK to navigate future challenges and opportunities, both in the UK and globally, and deliver for its members. Its far-reaching and forward-thinking nature will enable the pursuit of long-term ambitions, ensuring continuity of vision in the years ahead.

Our Vision

ENTUK’s vision is for a world where ENT and head and neck medical professionals can succeed and provide the best healthcare to patients.

Our Mission

We will achieve our vision by inspiring excellence and shaping the future of ENT and Head and Neck healthcare. This will be supported by three enabling strategic goals of influence, inclusion and growth.

Our Values

The strategy will guide the direction of our development and utilise our pivotal values of teamwork, ambition, respect, innovation and quality to ensure the success and future sustainability of the Association.

Collaboration

We are committed to building meaningful relationships with other organisations. Collaboration is key to achieving our vision and we are delighted that the new strategy has been endorsed by The Royal College of Surgeons of Edinburgh, The Royal College of Surgeons of England and The Royal College of Physicians & Surgeons of Glasgow.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

3

Following ratification at the ENTUK AGM in February 2023 our official name formally changed from ‘ENT UK trading as British Academic Conference in Otolaryngology (BACO) and British Association of Otorhinolaryngology - Head & Neck Surgery (BAO-HNS)’ to ENTUK.

The following sets out the management and governance of ENTUK during this financial year.

ENTUK office

The Board of Trustees

Demitted from the Board of Trustees:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

4

The Executive Committee

Demitted from Executive Committee:

The Finance Committee

The Education & Training Committee (ETC)

Demitted from ETC

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

5

The ENTUK Foundation Committee

The ENTUK Council

Regional Council Members

Demitted from Council

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

6

ENTUK Annual General Meeting (AGM)

The AGM for 2022-2023 was well attended and took place on 16 February during the second day of BACO 23. We had a minute’s silence to remember colleagues, including Prof David M Baguley, who had all sadly passed away during the year.

I was pleased to share highlights of the year, especially ENTUK's amalgamation with BRS and new partnership with AOT. The Association’s new website, Equity, Diversity and Inclusion Strategy and Action Plan, and new patient information leaflets with QR codes had all been launched. A bespoke Medical Indemnity insurance scheme with Howden Insurance Brokers Ltd had been negotiated. The success of the ENTUK Foundation was applauded, as was the Association’s silver award for the Newsletter.

Mr William Hellier, ENTUK Honorary Treasurer provided a clear summary of the Association finances. He proposed a 5.5% increase in membership fees that was approved by the members present without comment.

Special Resolutions were approved by members to update the Articles to simplify the legal name of the Association to ‘ENTUK’ and to correct the process for Trustee appointment, allowing for the appointment of no less than two Lay Trustees and bringing the Articles up to modern standards.

Miss Kay Seymour (Past Honorary Treasurer) and Miss Catherine Spinou who had both stepped down over the past year were thanked for their excellent contribution and support on the ENTUK Board of Trustees. Prof Philippa Tostevin was thanked for her excellent work as Director of Education, and Miss Wendy Smith was welcomed as her replacement.

ENTUK CEO Miss Katie Nurcombe then launched the Association's five-year strategy, ‘Inspiring Excellence and Shaping the Future’, and ENTUK President-elect Miss Helen Cocks announced that the next BACO would take place in 2026 in Newcastle.

Prof Janet Wilson was congratulated on being awarded the prestigious College Medal by the Royal College of Surgeons of Edinburgh. Finally, attendees congratulated Prof Nirmal Kumar on his award of Honorary Membership and Mr Tim Mitchell on his election as President of the Royal College of Surgeons of England, celebrating the fact that an ENT surgeon had attained this high office for the very first time in the long history of the College.

Mr Andrew C. Swift ENTUK President

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

7

At the start of the 2022/23 financial year, there were just over 2,400 paying members. ENTUK welcomed 369 new paying members but lost 458 paying members. The majority of the members lost were Student and Foundation members who were still in the early stages of their ENT career or Consultant members opting to retire from practice. This meant there were 2,370 paying members at the end of September 2023. This is a 2% dip in the headcount after the last few years of double-digit growth in headcount.

Despite a small dip in the membership headcount in the year, the membership income for the year was still strong and up by 8% this financial year compared to last year. The increase in revenue was due to various factors including the rise in the membership subscription at the start of the financial year, current members moving up the membership grades and higher-value members leaving the association late in the year for various reasons.

Membership income by year

Year Revenue YoY% Head count Head count YoY%
2014-15 325k 1,262
2015-16 342k
5		 1,340 6
2016-17 371k
8		 1,387 4
2017-18 410k
11		 1,485 7
2018-19 411k
-		 1,617 9
2019-20 434k
5		 1,880 16
2020-21 448k 3 2,117 13
2021-22 448k - 2,427 15
2022-23 481k 8 2370 -2
Paying members by grade Thisyear Lastyear
Total 2370(-57) 2,427
Consultant 558(-33) 591
Trainees 555(+15) 540
SFO 556(-56) 612
International 204(+2) 202
YCOHNS 171(+26) 145
Associate 149(-14) 163
Allied 120(-) 120
Retired 57(+3) 54
Free members Thisyear Lastyear
Total 331(+31) 300
Hinari 192(+43) 149
Life 81(-) 81
Honorary 47(-) 47
Parental leave 11(-12) 23

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

8

Membership Developments

We continue to promote a new tailor-made Medical Indemnity Insurance Scheme which was launched in 2022. ENTUK arranged for Howden Insurance Brokers Ltd to provide this scheme, to ensure that members can access suitable, up-to-date indemnity cover and protection. The risks inherent to frontline surgery mean that access to suitable indemnity cover is vitally important to our members, as well as to the specialty in general.

The ENTUK website continues to evolve and we are pleased that members are using the new members’ area to register for events, submit abstracts and apply for grants and fellowships. We will continue to upgrade the section for professionals to help members to better navigate our growing library of highquality resources.

You can read more about the impact we are having for our members in the following chapters.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

9

BACO International 2023

The indisputable highlight of the year was BACO International 2023 which was held in February in Birmingham. This eagerly anticipated event was the first inperson BACO since 2018 after Covid restrictions meant that BACO 2020 was first postponed and then hosted virtually. The Birmingham ICC as a venue proved highly successful but had originally been confirmed for BACO 2020. The ambitious programme featured nine simultaneous streams and over 180 sessions across three days . 1,417 delegates attended the event, and we were delighted to receive such positive feedback (delegates rated the event an excellent 4.7 out of 5).

ENTUK President Mr Andrew Swift officially commenced proceedings with a brief opening ceremony welcoming speakers and delegates to the conference. He thanked the BACO Executive Committee consisting of Academic Chair Prof Claire Hopkins; BACO Project Lead Prof Chris Raine; Industry Partnership Lead Mr Declan Costello; President-elect and now BACO 26 Chair Miss Helen Cocks and ENTUK Conferences and Events Manager Miss Amber Wilson for their hard work organising the hugely impressive conference. He also thanked the specialty leads and everyone involved in supporting the Academic Chair with the programme.

Prof Mahmood Bhutta gave the first plenary lecture ‘ Surgery and health supplies: Harming our planet and harming workers' rights ’. Mahmood’s lecture was an inspiring and impassioned look at surgery’s carbon footprint and how we can minimise it. Mahmood considered everything from the elevated

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

10

presence of microplastics in surgical theatres to the damaging dynamics created within healthcare systems by linear annual procurement cycles of medical equipment.

On the second day, former Conservative MP and Under-Secretary of State for Public Health Anna Soubry’s gave the second plenary lecture and explored the question ‘ Where now for medicine in the UK? ’ She drew on her ministerial experience, discussing some of the issues and crises currently affecting the NHS and concluding that widespread reform of social care is required to solve these, but that such reform is a victim of the drive toward short-term thinking in central government.

A centrepiece of the second day was our dedicated GP and Allied Professionals Day . Focused on topics identified by GPs as particularly challenging to manage in the community, the special GP Day constituted an entire day-long series of events and sessions designed to improve primary care in ENT.

Meanwhile, surgical simulation stations were set up for our dedicated SFO Clinical Skills Day , as students tried their hand at all manner of ENT procedures. The SFO Day was designed to inspire and cultivate the next generation of ENT surgeons.

Our third and final plenary lecture was led by Dr Rachel Clarke, palliative care doctor and author of bestselling non-fiction on life in the NHS. This thoughtprovoking and passionate lecture ‘ Death, Lies and Videotape: Doctors in the Media ’ considered the situation of doctors and healthcare professionals in the media and the position of trust we generally occupy in the public consciousness. She remarked that given the crucial social value of our work, we have both the right and the responsibility to advocate for our profession at every turn.

An important cornerstone of the third day was our first-ever Audiology Day , a brand-new initiative designed to cultivate ties and deepen the understanding between ENT clinicians, audiologists and audiological scientists. The all-day programme of audiology-based sessions and events was deemed a great success, and we can no doubt expect it to become a regular feature of future BACOs.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

11

The programme featured 21 international keynote speakers, instructional sessions, advanced updates, panel discussions, symposiums, debates and eponymous lectures . Highlights included the:

You can read more about the involvement and experience of the ENTUK Membership Groups and Special Interest Groups in their individual reports.

Delegates were able to explore the fantastic BACO International posters in the Exhibition Hall. There was a huge selection of great contributions that were rotated each day. Oral presentations also took place daily, selected from the highest-scoring abstract submissions. This really showcased the breadth and depth of talent across our specialty and provided delegates with plenty of food for thought between sessions.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

12

The Networking Evening was a thoroughly enjoyable evening of food, drink and dance. More than 250 attendees came along to celebrate, catch up with old friends and make new ones. The music came courtesy of the excellent Arrhythmics, who got the whole room up on the dancefloor, and it's fair to say that a great time was had by all!

BACO delegates have free access to BACO recordings and there are 175 sessions to view online. The recordings were uploaded on a weekly basis, starting with the plenary and keynote lectures, giving delegates access to the great talks they may have missed on the day.

It was important that the event was funded sufficiently to break even, and as such, an optimistic sponsorship target was set, knowing that this would be a challenge due to the lasting impacts of Covid. We are immensely grateful to all our sponsors and exhibitors , the delegates enjoyed the lively and engaging Exhibition Hall where companies of all sizes and from all backgrounds were represented.

BACO 2023 – Exhibitors Hall

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

13

Following a review of the final budget we were all relieved that the event made a small surplus, especially having set the delegate fees as low as possible to help support our trainees. ENTUK Trustees have been fully supportive of keeping this year’s BACO surplus within a designated fund for BACO 2026.

Finally, we are delighted to announce that ENTUK has won the silver award for 'Best Development of an Existing Association Event' and the bronze award for 'Best Longstanding Association Event' in the Association Excellence Awards 2023 for BACO International 2023!

The results were announced on Friday 3 November at the Awards Ceremony which took place at the De Vere Grand Connaught Rooms in London and was attended by representatives from the BACO 2023 Executive Committee, ENTUK team, Trustees, Executives and invited guests. This is just amazing news and many congratulations to the ENTUK team, friends and colleagues who made this happen. Particularly to Mr Andrew Swift for his hard work over several years coordinating such a successful event.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

14

Clinical Guidelines

During this financial year, ENTUK has worked with external organisations and our ENTUK sub-groups to develop new and update existing guidelines for the benefit of all those working within ENT departments. We have also provided guidance to GIRFT and other organisations to ensure consistent guidance and recommendations.

ENTUK worked with NHS England on their Decision Support Tool project. The final version of ‘ Making a decision about recurrent tonsillitis in adults and children ’ now includes data from NATTINA. The resource is designed to help explain treatment, care and support options and assist with shared decision making. The layout and corporate design of the document is set by NHS England. Local Anaesthetic Rhinological Surgery (LARS) guidance was developed by the British Rhinological Society (BRS) due to the increasing interest in performing procedures under local anaesthetic. The comprehensive guidance includes current applications, guidance regarding submitting a business case, anaesthetic considerations, equipment and setting as well as outcome measures, safety and clinical governance.

BRS also produced guidance on alternative nasal medication to flixonase nasules as the current manufacturer will cease production in the UK from December 2023. Another pharmaceutical company will produce flixonase nasules and members may wish to liaise with their local hospital pharmacy regarding the availability of flixonase nasules and alternatives as supplies may vary nationally.

The British Society of Otology (BSO) has created guidance for the management of adult hearing loss in primary care and recommendations for community management of hearing loss/ aural blockage. Both documents will help our Primary Care colleagues manage these conditions and the appropriate referral timeline when specialist input is required.

The Outpatients numbers guidance is currently being updated in light of the results from the survey conducted by ENTUK.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

15

ENTUK was asked to consider including choking as a potential indication for tonsillectomy in future tonsillectomy commissioning guidance. This was a Coroner’s request after the death of a toddler with a history of recurrent choking episodes, sleep-disordered breathing and documented large tonsils. Detailed guidance regarding identifying children who may be potentially at risk, referral and assessment guidance as well as implications regarding impact on referrals numbers are currently in development.

Global ENT Guidelines have been prepared as a joint project between ENTUK (Global Health Committee) and Global Otolaryngology and Head and Neck Surgery (OHNS). The aim of these guidelines is to provide a free resource, readily accessible, for anyone providing ENT care in resource-limited settings, with a focus on succinct, practical guidance for village health workers or limited resources. The group includes authors from high and low resource settings and come from all over the world. It is a resource that is continually developed with chapters added when completed.

We have committed to lead activity in relation to sustainability in ENT and Head and Neck healthcare . As a starting point, we want to address the areas which are most relevant and where we can have impact. These are suction, flexible nasal endoscopy and outpatient instruments. We plan to develop and publish guidelines on these areas to give our members confidence in taking decisions that are best for their patients and the planet.

Miss May Yaneza

ENTUK Honorary Secretary

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

16

ENTUK Patient Information

This year ENTUK published the first titles in a suite of brand-new patient information e-leaflets. We started with 21 paper leaflets to review and the project has grown from strength to strength. We currently have a total of 38 published e- leaflets online (6 ear, 14 nose, 8 throat, 10 head and neck). These have been developed by our patient information team alongside ENTUK members acting as authors, reviewers, and contributors.

The new e-leaflets can be found in the ‘Conditions and procedures’ section of the ENTUK website and include titles on septoplasty, flexible nasal endoscopy, thyroid surgery, adenoid surgery and tonsillectomy, to name just a few.

We have designed the e-leaflets to help patients seeking information about ENT and head and neck conditions or procedures. They are simple to access, free to use and available to all , reflecting our mission to inform the public about our specialty, promote understanding of the conditions we treat, and support our members by helping improve patient care.

Authored and reviewed by experienced ENT surgeons, the e-leaflets reflect the tremendous expertise available within the ENTUK membership. They are a fantastic resource for both patients and clinicians and can be used as a helpful aid to help answer patient questions and talk them through the decisions they may face.

New leaflets, produced by the ENTUK Community Group , are hosted on the patient information section of the website. These include ‘how to use ear drops or sprays’ and ‘how to use nasal drops’. This will be a great resource for GPs with an extended role in ENT and allied professionals who care for ENT patients in the community. These leaflets are also used in hospital outpatient clinics.

The complication rates quoted are based on a review of the literature on the subject and can have a large range as a result. Individual surgeons are encouraged to provide patients with their own complication rate based on an audit of their outcomes.

Funding has been allocated by the Board of Trustees for professional illustrations which also meets our commitment to equality, diversity, and inclusion. The example below shows illustrations from the e-leaflets designed to reflect the diversity of the British population.

To make them as user-friendly as possible for patients and healthcare practitioners alike, all leaflets have a unique QR code to make it easy for patients to download the content during consultations. This also is in line with our sustainability agenda. The e-leaflets can also be downloaded as a PDF or printed

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

17

out and supplied to patients who do not have access to a smartphone or computer to help them process complex information at home.

The e-leaflets are hosted on Healthinote , an online library of leaflets and similar material for use by GPs and primary care professionals, further promoting accessibility to high quality information.

Health literacy is a crucial consideration in the preparation of patient information. We aim to reduce the reading age of our patient information pages to the UK average of 8-10 years old and are collaborating with the Patient Information Forum (PIF) to achieve this. Tools such as the Flesch-Kincaid readability calculator are now used at key stages of the editorial process, enabling us to determine the reading age of the e-leaflets. ENTUK has signed up to the PIF Charter and is using their resources to improve and formalise the documentation processes around the development of the patient information e-leaflets.

A key ambition for the e-leaflets is to translate them into the most spoken languages in the UK and the patient information team is currently investigating leads into potential translators, translation services and associated costs.

In the next phase of the project, the patient information team would like to explore British Sign Language (BSL) videos for the deaf community. The team is also exploring the possibility of illustrating simple procedures and producing ‘ easy-read’ versions of the e-leaflets, featuring less text and more images to ensure additional accessibility. We have met with the Down’s Syndrome Association to agree in principle a mutually beneficial working relationship which would allow us to produce easy-read versions of our current leaflets for people with learning difficulties including people with Down’s Syndrome.

The Patient Information Project is ongoing, with 22 leaflets currently being reviewed by ENTUK members who are experts in the field (11 ear, six nose, two throat, three head and neck) and new titles still in development. These will be published on the website as we complete them. We aim to review the e-leaflets every three years with a patient information lead in every subsection.

Please get in touch if you would like to be part of the clinical team!

Miss May Yaneza ENTUK Honorary Secretary

Miss Nashreen Oozeer

ENTUK Patient Information Clinical Lead

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

18

National Clinical Impact Awards

At the beginning of 2023, important changes were announced with regards to the new National Clinical Impact Awards (NCIA) scheme, compared with the National Clinical Excellence Awards scheme which completed in 2021. These included an increase in the number of awards and a restructuring of the scheme. Applicants previously had to apply at the lowest level and work from bronze > silver > gold > platinum.

Non-stratification of the new awards meant that high-scoring applicants could achieve the highest-level award at their first application. New awards are valid for five years, a new application must be made when an award expires and there is no renewal process. New awards are non-pensionable. Citations are no longer needed but employer support is required before submission. The impact of roles above-and-beyond applicants’ job plans remained a key focus, with Equality, Diversity and Inclusion impacts also taken into account.

New NCIA National Nominating Organisation regulations meant that applicants could still seek general guidance from ENTUK, but that the individual guidance we were previously able to offer was no longer possible. Professor Nirmal Kumar and Miss Emma Stapleton ran a webinar on the NCIA process in March which explored the 2023 NCIA competition in England and Wales, how the award scheme worked, who could apply and how to maximise chances of success. ENTUK was also pleased to share application guidance with members. We expect to hear who has been successful in 2024 and we wish everyone the best of luck with their applications.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

19

Mentoring

ENTUK Mentoring Scheme

Hosted and led by WENTS UK

Since launching its mentoring scheme in February 2020, just prior to the pandemic, WENTS UK has matched and supported volunteer mentor-mentee pairings. The scheme has been more formally promoted and supported by ENTUK to widen access and no longer be restricted to WENTS UK members. We currently have over 120 matched pairs. Some of these have completed an 18month course and some pairings have refreshed.

The first Mentoring Fellows started their accreditation in Mentor Supervision in 2023, and should complete this by 2024. Recruitment for the next round of Mentor Fellows, to start in 2025, will take place in 2024:

Since the two virtual courses in 2022, we have run an in-person Mentor Training course in June 2023, heavily supported financially and logistically by MED-EL, to whom we are very grateful. The course was delivered to be as inclusive and accessible as possible to any attendees regardless of personal and health circumstances. The course was as well received as the previous virtual ones. We are now working to look at how to maintain accessibility to this course for current and future volunteer mentors. The current fellows, Ms Rujuta Roplekar Bance and Miss Emma Stapleton, received a £1,500 grant from the ENT Foundation towards funding the Mentor Training course.

We continue our support and networking of our volunteer mentors with Virtual Mentor Cafes. These safe spaces allow support, reflection and practice improvement for our mentors. The last café identified a need for additional support regarding signposting, and a resource for this will be uploaded to the ENTUK WENTS Mentoring Webpage:

• https://www.entuk.org/about/groups/wents/mentoring.aspx

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

20

We continue our drive to support diversity and inclusion while increasing our pool of mentors. We continue to welcome those mentees seeking a mentor. Members can register their interest as a prospective mentor or mentee at

• https://www.surveymonkey.co.uk/r/HGXXJDV.

We would like to take this opportunity to acknowledge and thank all our mentors, who are kindly volunteering within the scheme – it would not exist without your kindness, effort and engagement.

ENTUK CESR Buddy Scheme

Each year, fewer than ten ENT specialty doctors apply for specialist registration via the CESR route in the UK. This is an expensive process and the support for these doctors in preparation for their submission is variable around the UK, due to the variety of experience that may be available in each region. The aim of this voluntary ‘buddy’ scheme is to provide informal support and advice to a colleague in order to maximise their chance of success in what is a very expensive process.

There has been great interest from our consultant members in supporting this mentorship scheme. Mentors have been able to support colleagues through the CESR process as a result of their own experience of applying via this route. We are enormously grateful for this mentorship and the support of surgeons who will take an alternative pathway through their career development in ENT.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

21

The ENTUK Foundation

Since the launch of the ENTUK Foundation as the philanthropic and fundraising arm of ENTUK in September 2021, it has gone from strength to strength in pursuit of its vision to improve ENT healthcare for all. The Foundation seeks to achieve this by:

In undertaking its vision, the ENTUK Foundation will seek financial sustainability and longevity through fundraising and other income-generating activities as to not draw on ENTUK operating resources.

The Foundation has been very successful again in raising sufficient funds to support another round of ENTUK Foundation Awards this year. The ENTUK Foundation agreed to fund 24 Research Grants (totalling £23,300) and five Education Grants (totalling £7,000). We were grateful to receive further offers of donations from legacy, personal donors and industries which will enable the Foundation to fund further awards and activities to achieve its vision. A full list of our donors can be found on the ENTUK website.

The recipients of the ENTUK Foundation Research and Education Grants were announced at the ENTUK Research Showcase event in September at the Royal Society of Medicine in London. Delegates also heard from the Rowena Ryan Award finalists, and we congratulate all the winners of these National Awards.

This year we were pleased to present a special ENTUK Foundation Award at a Networking Evening event held in London in September. The Andrew Foster Leadership Grant is a special leadership-focused award in honour of founding Foundation Committee Member Mr Andrew Foster, who sadly passed away in March.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

22

Congratulations to Miss Anna Slovick who received this prestigious award for the development of The Women in ENT Surgery Foundation in Leadership Course. At this event, ENTUK President-elect Miss Helen Cocks congratulated Mr Vasant Oswal who had been awarded the Life-time Trainer Award 2023. Congratulations also go to Mr Jeremy Lavy who was awarded the Best Trainee Nominated Trainer Award.

The Foundation Committee and its Advisory Group have also worked hard to establish a sustainable model of enhancing international collaborations and seek to do this by engaging with colleagues from all over the world. BACO 2023 was a great opportunity to support doctors from Hinari A and B low-resource countries from around the world to visit Birmingham and enjoy the rich academic and cultural experience and in-person networking opportunities. 10 fellows from Kenya, Nigeria, Pakistan, Sri Lanka, Uganda, Ukraine and Vietnam were sponsored by the Foundation.

‘The academic program was excellent in providing me with an insight into all aspects of my profession, from otology, rhinology, and skull base surgery to head and neck surgery and facial plastic surgery. I had eye-opening lectures and updates that took me to another level of ENT knowledge. I am inspired by innovative techniques that have not been used at my department, and I am eagerly looking forward to applying my ideas to my medical practice to give the best care to my patients in my home country.’ Miss Nhu Ho - BACO 23 Fellow – Vietnam

The Foundation will continue its activity focused on research and education, social responsibility, professional development, patient and public involvement and engagement, and celebration.

Professor B Nirmal Kumar

ENTUK Foundation Committee Chair

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

23

Equity, Diversity and Inclusion

Our Equity, Diversity and Inclusion goals are that:

In this financial year, ENTUK delivered its first Equity, Diversity and Inclusion Strategy and Action Plan. Regular reports were provided to Trustees during the year and a brief update can be found below:

A new Action Plan for 2023/24 will be produced in line with the ENTUK Business Plan.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

24

This report covers a period of two Directors of Education (DoE) for ENTUK. Professor Philippa Tostevin handed over the role to Miss Wendy Smith at the end of February, so this is a combined authorship report.

The ENTUK Education and Training Committee (ETC) meetings took place virtually this year. The ETC consists of representation from the leadership of established educational groups including the ENTUK Continuing Professional Development Committee, SFO, SAS, AOT, SAC and the ENTUK Community Group. Updates have been provided to the ENTUK Executive Committee, Board of Trustees and Council throughout the year.

This report represents a summary of educational activities to demonstrate how they have progressed in alignment with the mission statement of ENTUK, noting the strategic objectives and key deliverables in the previous 5–10-year strategy document.

1. Mission statement:

To promote an understanding of the range of conditions treated by the specialty

e-lefENT

Lead: Mr James Tysome and Ms Somiah Siddiq

The Director of e-learning, Mr James Tysome, and Editor-in-Chief of e-lefENT, Ms Somiah Siddiq, have continued to collaborate with the digital transformation team from Medtronic who support the virtual learning platform.

The initial phase of focus for e-lefENT has been the review, edit and update of existing learning zone modules (produced mostly in 2012/13) in conjunction with the production of new modules to reflect current gaps within the FRCS syllabus and essential core knowledge for clinical practice. This year, the content has been updated with 26 new modules, including some for the general practitioners with an interest in ENT. This continuous evolution of the platform provides a highly valuable current resource for trainees and for CPD refreshers for everyone.

Under the new strategy objective of ‘Shape the Future’, a Review Group has been set up to reflect on the current e-learning platform, its usage, and what innovative technologies can be introduced to enhance the learning experience for ENTUK members. A survey providing feedback was completed in July 2023 and the results of this will be used to evolve the platform.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

25

2. Mission statement:

To support and provide continuing education for specialists

CPD

Lead Miss Marianne Elloy

The Continuing Professional Development (CPD) Committee led by Miss Marianne Elloy has provided kite mark accreditation on behalf of ENTUK as a marker of quality of educational provision. Over this period, 21 applications for CPD approval were received (including one for an ear care course that could not be accredited). Three were received for advertising only. ENTUK is currently not providing accreditation for microsuction courses. Quality assurance visits to courses or virtual reviews of course content, including feedback from all courses, were conducted and action taken if required. An additional clause to applications to consider the diversity of the makeup of any faculty has been added this year.

Webinars

Lead: Vacant

We would like to thank Mrs Mira de Kruifj for her work with producing the webinar series, which is a free resource that is livestreamed through the Royal College of Surgeons of Edinburgh (RCSEd). This popular second series attracted an international audience of trainees, specialty doctors and consultants. The webinars are also stored in the Education Library on the ENTUK website and represent a valuable resource for trainees. A new Webinar Lead will be advertised.

Paediatric Emergency Surgical Skills Course (PESC)

Course Leads Mr Michael Saunders and Mr Neil Bateman

This simulation course has been developed primarily to support ENT consultants who cover emergency work but who do not work in tertiary paediatric ENT centres. No course was delivered this year.

Adult Emergency Surgical Skills Course (ESSC)

Course Lead Mr Raj Lakhani

No course was delivered this year. It is hoped that the course will be delivered again in the next academic year and discussions with a new venue are ongoing.

Podcast development

Lead Mr James Tysome

Mr James Tysome devised the concept of ‘A coffee room chat in ENT’, gained the support of RCSEd and then organised and edited a new series of podcasts held by ENTUK in collaboration with them. The second series included the following topics:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

26

Education Library

The Education Library is a valuable repository on the new website for useful educational resources such as the top performing BACO lectures and also induction lectures for doctors new to ENT.

ENTUK Foundation Awards

Successful recipients of the ENTUK Foundation Education Grants were announced at the ENTUK Research Showcase meeting in September:

3. Mission statement:

To encourage recruitment into the specialty

Association of Otolaryngologists in Training (AOT)

A key educational relationship that has been actively nurtured throughout the year is that between ENTUK and the AOT group. The president of AOT and the education representatives have been active contributors to the Education and Training Committee and as such, provide a key bridge of essential communication between the organisations. A formal partnership agreement has been agreed with ENTUK and AOT.

Medical Training Initiative (MTI)

The MTI scheme is run by Health Education England (HEE) on behalf of the Department of Health (the government sponsor) operating under the Home Office Tier 5 Government Authorised Exchange visa scheme. In alignment with

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

27

the strategic objective to run an effective recruitment scheme for MTI, ENTUK aims to sponsor clinical training and improve the quality of healthcare in developing countries. Three MTI doctors were accepted for training in the UK during the period covered by this document, interviewing by videoconference by an ENTUK executive representative and host trust representatives. The process of appointing a new MTI doctor has become increasingly complex so a guide has been produced that is available on the website to help people navigate the new process. Doctors were appointed to Carlisle, Southampton and Shrewsbury.

4. Mission statement:

To promote high standards in the training of specialists

Recruitment

National selection in 2022 took the form of a virtual portfolio review. There is a considerable cost benefit to this approach that evolved due to the pandemic restrictions, so it seems likely that this virtual approach will continue. The highestscoring candidates were interviewed over a virtual platform on 23 and 24 March 2023. The ENTUK Director of Education supported the quality assurance of the process working with the national selection team in Yorkshire and Humber.

Specialty Advisory Committee (SAC)

A key relationship between educational committees and ENTUK is maintained by the ENTUK President-elect and the Director of Education sitting on the SAC, while SAC Chair Miss Ann-Louise McDermott is also a member of the ENTUK Executive Committee and the ENTUK Education and Training Committee. An innovation this year has been the development of a new ENT Trauma Course to support trainees who are following the new Otolaryngology curriculum.

BACO GP Day

A successful day for GPs with an extended role in ENT and allied health professionals was held on the second day of BACO 23 in February. The day covered areas that were identified by the ENT Community Group and the attendees of the previous BACO GP Day as topics of interest to the group. The feedback for the day was very positive and will hopefully be a feature of future BACO conferences.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

28

5. Mission statement:

To represent the specialty at the Royal College of Surgeons

Fellowships

ENTUK provides support to the RCS England fellowship scheme by reviewing applications from teams who wish to provide a fellowship. In the last year, review and support of fellowship applications has been undertaken for the Liverpool Rhinology Fellowship, the Senior Clinical Fellowship in Laryngology at the Deenanth Mangeshkar Hospital in Pune India, Bangladesh and the Imperial Laryngology Fellowship.

Final Note

The work of the SFO Group (led by Mr Dheeraj Karamchandani) and the Community ENT Group is fundamental to the success of the educational activity. Full reports on their activity can be found in section nine of the Annual Report.

ENTUK Education and Governance Officer, Ms Janet Stephen has provided outstanding support for all educational activities over the last year, and we would like to thank her for her contribution.

Miss Wendy Smith ENTUK Director of Education

Professor Philippa Tostevin Past ENTUK Director of Education (December 2018 to February 2023)

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

29

Lead by Miss Ann-Louise McDermott

I am pleased to have been the SAC Chair since January 2022.

Training update

As of September 2023, there is no evidence of improvement in trainee logbooks post covid and now there is further compromise to training experience by continued Industrial Action, which appears to be an issue for the foreseeable future. Covid outcomes are no longer valid from 30 September 2023.

This again emphasises the importance of simulation training for all trainees and being innovative at identifying opportunities to maximise training.

Curriculum

The 2021 curriculum has now embedded well into Otolaryngology training. Future curriculum updates and changes will be made in a more dynamic fashion from summer 2024, with yearly updates as required. This is in contrast with previous curriculum changes which happened every 3 years.

Simulation

As mentioned above, more emphasis on simulation is needed.

The ENT themed trauma course continues to be held across the UK for senior trainees in line with their CCT requirements. This course fulfils the GMC mandated ATLS aspect of the curriculum.

Two Bootcamps took place in this financial year and continue to be well attended and have had excellent feedback:

National Selection

The 2023 Portfolio assessments took place in January 2023. There were 147 applicants and 87 were invited to interview in March 2023. 60 posts were offered in total (nine LAT posts in Scotland).

The self-assessment criteria changed this year and plans are in place for further changes to the portfolio in the future.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

30

----- Start of picture text -----
BACK TO THE
TABLE OF CONTENTS
----- End of picture text -----

Despite relentless lobbying of the MDRS to reconsider or find a hybrid alternative for National selection, it will once again be held on a virtual platform in Spring 2024. Dates will be released shortly.

Core Training

In November 2022, the mandatory MSRA examination was used as a shortlist tool for more than 2,500 applicants. The 1,200 with the highest marks submitted a portfolio and attended for interview. The long-awaited new core curriculum is still awaited by all. Run through training is not offered for Otolaryngology.

Workforce

The redistribution of training posts has started in England in parallel to the expansion plan for trainees. Training numbers are changing in each region later this year.

Finally, I would like to thank all the members of the SAC for all their hard work this past year.

Miss Ann-Louise McDermott

Chair of SAC in Otorhinolaryngology

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

31

British Rhinology Society (BRS)

It has been another excellent year, particularly following our successful May BRS/BRS Juniors meeting in Winchester, which was met with bright sunshine and a full attendance. Thanks again to Mr Ashok Rokade, BRS/BRS juniors team and ENTUK for putting this inspiring meeting together. At close of play, Mr Raj Bhalla handed over the ‘Presidential reins’ and was congratulated on his impressive tenureship, in particular, overseeing BRS during the post-COVID era.

Moving forwards, rhinology continues to face challenges within the NHS and I’m keen to work closely with NHSE in keeping us on the map. Our standardised rhinology surgical pathways which include endoscopic sinus surgery and nasal airway surgery can now be found on the ENTUK website. These pathways have been signed off by the BRS, BSFPS and ENTUK and have been ‘set out’ in a robust and evidence based format, ensuring our subspecialty gets the ‘air time’ it deserves within the corridors of NHSE.

On a separate note, the BRS will continue to lead and update on ‘guidance and recommendation’ statements which includes our recent statement on alternative steroid spray/drop use following the news that GSK will cease to produce flixonase nasules. On a positive note, alternative drug manufacturers will be producing flixonase nasules in due course.

In addition, congratulations to Mrs Archana Jaiswal on putting together our BRS/BRS juniors mentoring scheme which went live this year and has proven to be incredibly successful. Equally, our Olympus BRS-ART fellowship scheme continues this year.

I would also like to congratulate Mr Saleh Okhovat on his successful election to the BRS Council, representing Scotland/Northern Ireland as well as being our Sustainability Lead.

I very much look forward to catching up soon and if not this year, see you next May at our Cardiff BRS/BRS Juniors meeting which will also have a special RSM twist!

Prof. Peter Andrews

BRS President

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524 ANNUAL REPORT 2022 - 2023 32 |

ANNUAL REPORT 2022 - 2023 |

British Society of Facial Plastic Surgery (BSFPS)

It is just over a year since I took over as the President of BSFPS in July 2022. I would like to provide an update on what we have achieved as a team, over the last 12 months. Firstly, I would like to congratulate Prof Anshul Sama from Nottingham, who has been appointed as BSFPS President-elect. I have no doubt that he will take the society forward to new heights.

As planned, we have filled up all the council positions , regional representatives and updated the BSFPS website , along with a new section on the history and past presidents of BSFPS.

To address training needs, we held a successful series of six webinar lectures during this summer, by national speakers of repute covering a variety of facial plastic surgery topics with excellent trainee attendance. The two STORZ funded BSFPS Travelling Fellowships, which we managed to procure, have been advertised and we have had an excellent response. Interviews are scheduled for 3 October.

In the third week of May 2023, we successfully conducted the first post-Covid ‘face-to-face’ BSFPS dissection course in Nottingham which was superbly organised by Prof. Anshul Sama.

Two ‘coffee room chat’ podcast episodes led by our senior colleagues in collaboration with the RCSEd are available for members to listen to. Our scientific Program in BACO 2023 was a grand success, covering a variety of Facial Plastic Surgery (FPS) topics with national and international speakers, and excellent participation of trainees.

Our next BSFPS Annual Conference has been expertly organised by Ms Sadie Khwaja and Mr Rajeev Advani. The meeting will be held in Manchester on 12 and 13 October 2023. There will be a ‘Juniors Day’ on the first day which will be geared to trainees taking the exam. The main Programme on the second day will include lectures by faculty covering all aspects of FPS.

BSFPS, as part of the Intercollegiate Cosmetic Surgery Certification Committee is actively involved with sister organisations and the GMC, regarding the cosmetic surgery certification process. We would like to encourage established consultants to apply for the certification. To conclude, I am looking forward to the next 12 months of my tenure and hope to do more for the society. My personal wishes and kind regards to all members and their families.

Mr. Natarajan Balaji BSFPS President

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

33

British Society of Otology (BSO)

Now in its twentieth year, the highlight of BSO’s year was the annual conference and celebratory dinner at the RCS England in May. The conference was very well received. It focused on levelling the playing field with outstanding keynote presentations from Ms Suzannah Hext, paralympic world champion swimmer, and Professor Claire Hopkins. Thank you to everyone who contributed to the meeting. The dinner was enjoyable with original BSO Council Members mixing with current otologists. Next year’s conference will be held at the Royal College of Surgeons in Glasgow on 15 March under the capable supervision of Mr Arun Iyer.

The balance course continues to gain a great deal of interest both nationally and internationally. Thanks to Mr Gerard Kelly for his careful stewardship over the last few years and to Mr Owen Judd who has taken over the reins.

The Council remains the heart of our organisation. Thanks go to five Council members who demitted this year. We welcomed Mr Jonny Harcourt and Mr Nick Saunders to council. Mr Alex Yao and Mr Cillian Forde have taken over as the BSO Junior and AOT representatives respectively. We look forward to working with them over the coming years. Congratulations to Mr Peter Monksfield who has been elected as BSO President from March next year.

Financially, we continue to maintain a positive balance sheet which has allowed us to continue to support important activities. The small grants programme is in its third year and has produced several successful projects. A national tympanoplasty registry is currently under construction. Thanks to Ms Clair Saxby for obtaining a grant from the ENTUK Foundation to support this.

The BSO Juniors group continues to thrive. Initiatives this year include a mentoring scheme for otologists in training, a series of evening lectures from otology experts, a monthly paper review via social media and a careers evening. They are also working on clinical guidance for local anaesthetic ear surgery.

We have published guidance on the management of wax obstruction and continue to work with other stakeholders to lobby for change in how these services are delivered. We also contributed to other national guidelines over the year.

Feedback from BACO was excellent. Thank you to all who contributed, especially Ms Kay Seymour who led the programme development. We also supported other international conferences this year including the Chole 2023 meeting in Shanghai. We reached agreement with the European Academy of Otology and Neurotology that the UK representative on their board should be the ex-president of the BSO.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

34

This will strengthen links with our European colleagues and ensure we work more closely together.

We have made some changes to our constitution this year. We added a permanent representative for the BSO Juniors to Council and highlighted our commitment to equality and diversity.

That just leaves me to say thank you to Council and Ms Kay Seymour, who continue to work incredibly hard to maintain the BSO as the thriving organisation that it is.

Professor Simon Lloyd President of BSO

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

35

Community ENT Group

The Community ENT Group has continued to meet virtually, and its membership is growing. The Group consists of a diverse group of clinical professionals including GPs, General Practitioners with Extended Roles (GPwER) in ENT and Physician Associates. The Group continues to develop e-lefENT resources to reflect learning needs identified by the GPwER ENT curriculum. An e-learning module for ototoxicity was developed and submitted for addition to elefENT. Furthermore, topics for radiology in ENT and indications for tonsillectomy are in development.

The GP Day at BACO 2023 was a great success. The content of these ten 30minute sessions was based on the needs identified by the Community Group and feedback from the previous BACO GP Day. The topics were diverse including dizziness, sensorineural hearing loss/auditory processing disorder, allergic rhinitis, headaches, recognising oral cancer as well as discussion on the role of Physician Associates in ENT. The day was well attended and positively received by the delegates, and it was great to see the result of an in increase in the Community ENT Group membership.

The Group is also currently engaged in improving the visibility and availability of primary care resources that have been developed, to enable GPs to share these with patients in primary care. Leaflets include anosmia information for GPs to give to patients, ‘How to look after your voice’, Home Epley manoeuvre, and ‘How to use ear drops and sprays: a step-by-step guide’.

Dr Eason Sivayoham and Ms Wendy Smith

Community ENT Group Co-Chairs

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

36

Head and Neck Society

It has The Head and Neck Society have been busy during 2022 -23 with the main agenda item being the completion and submission for publication of the 6[th] Edition, Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines. This has been a huge project and the guidelines have been authored by over 170 UK based authors covering 21 specialities (Anaesthetics, Clinical Nurse Specialists, Dermatology, Dietetics, Endocrinology, ENT, Genetics, Oral Maxillofacial surgery, Oncology, Oral surgery, Palliative care, Pathology, Physiotherapy, Pharmacology, Plastic surgery. Psychology, Public Health, Radiology, Restorative dentistry. Speech and Language therapy and Vascular Surgery). They are endorsed by 12 national bodies:

Therefore, this is a truly multidisciplinary set of guidelines which multidisciplinary teams (MDTs) across the UK should find useful. I have had the privilege of seeing the ‘final draft’ and have no doubt that it will be a very well received and widely used set of guidelines. Congratulations should be given to Professor Homer and Mr Winter as co-editors for completing this challenging task.

There were no specific ENTUK Head & Neck Society academic meetings held in the 2022-2023 period largely due to the work required to complete the guidelines and of course BACO 2023. BACO was a great success from the Head and Neck Society’s view with most head and neck topics covered comprehensively by internationally recognised experts in the field and we also included many consultants in the programme who were relatively recently appointed to keep the presentations as contemporary as possible. We plan to go back to running the well-established ‘evidence based’ annual meetings in the future.

Professor Homer has commenced his post as GIRFT ENT National Lead for Head & Neck Cancer and will be reviewing MDTs throughout the UK helping and advising on how local services for Head and Neck Cancer may be optimised. He

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

37

plans to update the Head and Neck Society regularly at Council meetings which should be very useful. He will produce a national report for NHS England in 2024.

Mr Ricard Simo has now demitted from Council. He has been a very active member of the Head and Neck Society for the last 6 years (and probably more!) and his links with the BLA and European Societies have been very useful. I wish him the very best and thank him for all his hard work. We had two vacancies on Council and elections took place earlier this year and we are delighted to welcome our new Council members, Mr Jai Manickavasagam and Ms Sommia Siddiq.

Mr Sanjai Sood

Head and Neck Society President

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

38

ENT Staff and Associate Specialists (SAS)

We are pleased to report that there has been steady progress made thanks to the active involvement of SAS colleagues across UK. A ‘meet and greet’ webinar was organised in the summer.

We have had regular committee meetings via zoom, to plan the next SAS conference which is scheduled for June 2024. We are actively engaging with various speakers to organise an excellent programme to cater to the specific developmental needs of the SAS doctors.

More recently a survey was conducted to assess the needs of the SAS doctors. Results will be disseminated once it is available.

Further webinars have been planned and the topics and the dates will be announced in due course.

Finally, I am enjoying the role as SAS chair, and it is encouraging to see the enthusiasm from SAS colleagues across the country.

Mr Swaminathan Ramanathan

SAS Chair

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

39

Student and Foundation Doctors in Otolaryngology (SFO UK)

The SFO group has continued to support the training of members from medical school in alignment with the ENTUK strategy. The membership has continued to grow from 40 members in 2016 to nearly 500 members (at the time of writing). We hope that this enthusiasm can be maintained and translated into a vibrant future for the specialty by encouraging the next generation of ENT surgeons.

All medical schools now have representatives on the SFO group as well as all foundation schools. The Official Handbook for Medical Students and Junior Doctors e-book, produced by the SFO group, is freely available to all medical students in the UK and for many represents a core text for the curriculum. Work is ongoing to improve its functionality and alignment with the forthcoming GMC medical licensing exam. This update is planned for publication in 2024.

A highly successful SFO Day was held at the second day of BACO International 2023 with some exceptional speakers and practical skills stations. The skills stations were very popular with delegates and received excellent feedback. With the continued support of ENTUK, prizes were awarded to delegates including the Undergraduate essay prize (a tradition that dates as far back as 1981).

SFO reps have also continued to organise several events round the country over the last year to raise awareness of SFO ENTUK.

Mr Dheeraj Karamchandani SFO Chair

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

40

----- Start of picture text -----
BACK TO THE
TABLE OF CONTENTS
----- End of picture text -----

Young Consultants in Otolaryngology and Head and Neck Surgery (YCOHNS)

YCOHNS are gearing up for the re-launch event in Birmingham on 9 and 10 November. There will be a networking event on the first evening, which will include around 50 people for discussions about what is going on up and down the country in regards to experiences of consultants in their first five years. During the next day, the conference itself will include talks and seminars with exceptional speakers regarding job planning, education, leadership, management, private practice, and innovation. We will also hold an AGM during the meeting and discuss further plans for YCOHNS going forward with a large focus on improving the website presence and functionality.

Mr James Barraclough YCOHNS Chair

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

41

The British Otorhinolaryngology and Allied Sciences Research Society (BOARS)

BOARS aims to provide a forum for the best current research in ENT, Hearing and Balance in the UK. Two meetings are held each year that combine oral presentations in the style of the ORS with research education for academic trainees.

BOARS took part in the British Academic Conference in Otolaryngology (BACO) in 2023, running a popular educational session called ‘The Questions You Had About Research But Were Too Afraid To Ask’ on the funding and conduct of research. Mr James O’Hara spoke on how to set up and fund a trial, Mr Ian Hampton gave a fascinating and entertaining talk on his career and research and Mr Matt Lechner delivered the Hunterian Lecture outlining the pearls and pitfalls of his research career.

As a result of the BACO meeting, the spring meeting had a more educational emphasis and was delivered from the University of East Anglia. Academic trainees spoke about their progress in their research activity and there was a reflection on the PUFFIN trial (Professor Andrew Wilson, UEA), a talk on medical statistics by Dr Allan Clark, and a presentation on hearing loss and dementia from Professor Michael Hornberger. It was an opportunity for national trainees to network and learn from each other’s experience and was hugely popular with excellent feedback.

We held an Autumn meeting jointly with ENTUK on 15 September; we received a huge number of abstracts and the meeting was very well attended. The poster prize was awarded to Miss Madeline Gadd and the junior prize to Miss Marina Forbes, with the prestigious Philip Stell prize awarded to Miss Sumrit Bola.

Mr David Hamilton BOARS Secretary

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

42

British Society for the History of ENT (BSHENT)

The Annual Meeting of the British Society for the History of ENT was held in the Toynbee-Mackenzie ENT room at the Royal Society of Medicine on Thursday 1 December 2022. The first face-to-face meeting since 2019 was enjoyed by a full house of delegates ranging from medical students to long-retired colleagues who have enjoyed this annual event throughout their careers.

Many high-quality papers were submitted, indicating a healthy interest in the History of ENT among the younger generation! Eleven were chosen for presentation. A twelfth paper was presented by Professor Mark Wickham-Jones, a Professor of Political Science and Family Trustee of the TWJ Foundation, on the History of the TWJ Foundation as it approaches its 50[th] Anniversary. The TWJ Foundation offers generous grants and scholarships to Otologists in the UK.

The Journal of Laryngology and Otology (JLO) prize was won by Miss Emily Moore, with Dr Hamza Qureshi as runner-up, awarded by Mr Edward Fisher, JLO Editor and BSHENT Council member, and Mr Neil Weir, BSHENT President.

Award of the JLO prize to Miss Emily Moore (winner) and Dr Hamza Qureshi (runnerup) by Mr Edward Fisher (JLO Editor) and Mr Neil Weir OBE (BSHENT President)

At the end of the meeting, Mr Neil Weir thanked his co-chairs Mr Richard Irving and Miss Emma Stapleton, and the judges Mr Edward Fisher and Professor Albert Mudry, International BSHENT Council member. He also thanked Miss Pam Mohairir ENTUK Events Officer, for her excellent organisation of the meeting.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

43

Mr Neil Weir continues in his role as BSHENT President, with Mr Richard Irving, Mr Edward Fisher and Miss Emma Stapleton as Committee Members; Professor Albert Mudry as International Committee Member, and Mr Stefan Linton as Webmaster. Ms Katherine Conroy had completed her term as Trainee Committee Member, and in view of her recent FRCS success she was nominated and voted to join the BSHENT Council as a full member, with Dr Ruby Sekhon stepping into the Trainee Representative role.

The next annual meeting will be held on Thursday 30 November 2023, in the Toynbee-Mackenzie ENT room at the Royal Society of Medicine, Wimpole Street, London.

Mr Neil Weir BSHENT President

Miss Emma Stapleton BSHENT Ordinary Committee Member and Honorary Secretary

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

44

Global Health Committee

The Global Health Committee continues to develop its activities and strengthen its membership. Four new members joined in the past 12 months. Dr Leye Oyelakin trained in Nigeria and offers a valuable perspective. Dr Catherine de Cates and Dr Farizeh Ahmed are trainee ENT surgeons who both have an impressive involvement in global health. I am sure that they will inspire trainees to develop an interest in this area. We also welcomed Dr Aurelien Gueroult, who is a vascular trainee. Vascular surgery does not have a Global Health Committee and his intention is to start a group following his experience (he is a member of ENTUK!).

We had a successful annual Virtual Global Health Meeting in November 2022 with sessions on Research in Global Health, Global Health Politics and Sustainability and Head and Neck in Low Resource Environments. The speakers were truly inspirational, and it was wonderful to have such an array of experienced clinicians supporting the meeting. We also had a free papers session and awarded a prize for the best paper.

We had an excellent session on global health at the BACO 2023 conference. This included a talk by Dr Roman Fishchuk, an ENT Surgeon in Ukraine, discussing ENT services in a time of war and pandemic.

We have again reflected on ways of obtaining funding and this is still a work in progress. We have decided to reach out to institutions other than medical suppliers and look for sponsorship for our grants in particular which is an important part of the Committee’s work. We awarded three grants of £2,000 last year. One was to develop a tracheostomy education initiative and another was to set up a sustainable hearing health clinic, both in Uganda. The third grant went to Global OHNS, a research collaborative dedicated to promoting access to high quality, affordable otolaryngology care for all.

We are also collaborating with the Global OHNS on the ongoing project on ENT guidelines. This is an internet-based project, providing guidance on ENT conditions to cover a variety of resource settings. Guidance has been written jointly by ENT Surgeons in high, low and middle-income countries.

A new and exciting initiative centres on sustainability and recycling. This aims to provide equipment to areas of low resource, in order to support and develop ENT services.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

45

We are continuing to develop the global health website in collaboration with ENTUK. We have active social media initiatives run by Ms Baveena Heer and Mr Cheka Spencer and we have a large number of followers.

The Committee continues to be a stakeholder at the World Hearing Forum, a global network of stakeholders established by the WHO, promoting ear and hearing care worldwide. We also took part in a new initiative at The Royal College of Surgeons England, looking at ways in which global health organisations representing the various surgical specialties can collaborate and learn from each other.

We would like to thank ENTUK and the office staff for their help and collaboration during the past 12 months.

Mr Nick Eynon-Lewis

Chair ENTUK Global Health Committee

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

46

Private Practice Committee

This has been a quiet year for the Private Practice Committee due to various issues especially the ongoing industrial actions by doctors and consultants.

We continue to receive concerns from colleagues about fees paid by Private Medical Insurers (PMI) remaining stagnant for many years and not taking account of rising costs. This has a knock-on impact with colleagues both giving up private practice and new colleagues opting not to start. PMIs are unwilling to negotiate with either the BMA or the Surgical Specialty Associations. However, with rising rates for NHS work, there have been some recent changes and some PMIs have increased rates and hopefully others will follow.

We continue to engage with FIPO (Federation of Independent Practitioner Organisations), attended by a number of Specialty Association private practice representatives. Issues raised at FIPO have included:

We have also engaged with PHIN (Private Healthcare Information Network) and discussed issues of relevance. This includes the CMA ruling regarding independent practitioners publishing their fees being pushed, and that action will be enforced on colleagues that have not complied. Please ensure that you have checked and made your fees available.

PHIN are planning to publish consultant outcome data that is recorded on PHIN. This will be a “presumed” publication and therefore unless consultants raise a data query on their profile the data will be made public. We are engaging via FIPO and directly to ensure that this is undertaken appropriately but would urge colleagues to check the data held for accuracy and raise any queries.

We will continue to raise important issue at ENTUK Council. Please contact ENTUK if you would like any issues to be raised. We are unable to directly help with individual queries but can signpost to the relevant organisations that can help .

Mr Ram Moorthy

Private Practice Committee Chair

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

47

Women in ENT Surgery (WENTS UK)

February 2023 saw the handover to a new WENTS Committee at the AGM at BACO 2023, after hosting an engaging debate on tokenism versus meritocracy. This was followed by a well-attended networking event at the Ikon Gallery, adjacent to the International Convention Centre.

The WENTS and Friends podcast has had over a thousand downloads across thirty-four countries reaching number thirty-six in the UK medical podcast chart; discussions around training, menopause and pregnancy proved particularly popular with listeners. A further six podcast episodes have been outlined and will proceed to production once funding is secured.

The mentorship programme saw another round of matching, an excellently received training day in June in Sheffield, and has further training courses as well as six further mentorship cafes scheduled; more details can be found in the Mentoring report.

In March, WENTS researchers saw their first publication, by Dr Rohma Abrar and Miss Emma Stapleton, examining participant expectations of mentoring, with more projects presented, submitted for publication or in the pipeline. This will be built upon in the coming months to years, including up to a further three £500 Shyamala grants to be awarded in 2024, and a WENTS research group.

Miss Anna Slovick was awarded the Andrew Foster Leadership grant from the ENTUK Foundation in September, on behalf of WENTS, to establish a WENTS leadership course which will be run in 2024. This will be preceded by a series of three webinars on the theme of leadership, with the first taking place on 30 October featuring acclaimed speaker, and fighter pilot, Mandy Hickson.

The Committee is strengthening links with other surgical specialties; three members attended the Women in Surgery event at RCS England in September 2023, and several are due to attend the Stryker Women in Surgery event. We are also engaging with thousands of healthcare professionals across multiple social media platforms, via our social media representative Dr Alex Ashman.

Other areas of current focus include:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

48

The WENTS UK Committee feel that recently publicised, high-profile issues in the past year - including as the WPSMS report, the NHS staffing crisis, and correlations of surgical outcomes with both surgeon and patient genders – demonstrate the importance and relevance of our endeavours.

We would like to thank the outgoing Committee for their hard work and achievements and express our appreciation for the continued support of our members, the ENTUK Foundation, the wider ENTUK community, all our collaborators and sponsors, and everyone who has attended or participated in our activities of the past year.

WENTS UK Executive Committee

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

49

Overview of ENTUK finances: period 2022-2023

Introduction

This financial report covers the year from the 1st of October 2022 to the 30th of September 2023. This financial year has been an eventful year with the first physical BACO Conference being held for the first time since the pandemic.

Revenue

As a membership body, ENTUK’s main source of income is membership subscriptions. Total paid-up membership revenue for 2022-23 was £484k compared to £447k last year. The increase in revenue can be attributed to the 5.5% rise in subscription fees for the year and members joining to take advantage of members-only discounted delegate fees before BACO 2023 which was held in February 2023.

The total number of paid-up members on 30 September 2023 was 2,370 compared to 2,459 last year. Thus, there was a net loss of 89 members during this financial year including a net loss of 28 paying Consultant members. The Consultant members contribute 72% of our membership revenue and the ENTUK Trustee Board is taking action to ensure members see value for their membership.

BACO 2023 took place in February 2023 at the ICC, Birmingham which was a very successful conference, with excellent attendance (despite being held in February for the first time) supported by a strong scientific programme. The BACO Executive Committee worked extremely hard to ensure the registration for delegates was seamless and secured sponsors at a time when many companies were closely examining their sponsorship spend. ENTUK is very grateful to all its industry partners who attended BACO 2023 as sponsors and exhibitors for their continued support. Total revenue income from delegates and industry partners for BACO 2023 was £769k.

The British Rhinological Society formally joined ENTUK and brought with them £177k with an agreement to ringfence the cash for their future activities. This is a one-off activity and the £177k is technically a transfer of funds from one association to another. This transfer is included in the annual account to ensure transparency on the sources of income.

The ENTUK Foundation continues to be active under the leadership of Professor Nirmal Kumar and was able to secure £56k in donations, raised from individual and institutional donors, to fund research and international collaborations within the ENT specialty. This is ringfenced separately within the accounts as designated funds. ENTUK is extremely grateful to all our individual and institutional donors, for their generosity and support. A full list of donors can be found on the ENTUK website at https://www.entuk.org/donors.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

50

Investment portfolio

The ENTUK Finance Committee oversees all matters about the financial planning and performance of ENTUK, including investment management, and advises and reports to the Board of Trustees on the performance of the investment portfolio and the appointed fund managers. Brewin Dolphin has been our fund manager since 2010. Funds are invested in a wide range of products, with a restriction against investing in tobacco companies, companies with animal-tested products and funds with exposure to the Russian market.

The global economic turmoil affected all stock markets around the world. This has therefore affected the market value of ENTUK’s investment portfolio. The book value of the investments at the end of September 2023 remained flat at £2.1m. The market value on the 1st of October 2023 was £2.39m (compared to its valuation of £2.38m at a similar date in 2022). This valuation is inclusive of £46k withdrawn from the portfolio by ENTUK to fund strategic projects, as detailed in the reserves policy.

The portfolio revaluation on 30 September 2023 led to a gain of £75k compared to £429k deficit in 2022. Stock market values do fluctuate in the short term, but ENTUK has a long-term outlook for its investment portfolio.

The rise of inflationary pressures, and interest rates, have increased the income derived from the portfolio to a degree. The dividend income for the year was £54k (£55k in 2022). The forecast dividend income for 2023-24 is £59k. Due to the higher interest rate in the market, ENTUK earned £27k in interest income during the year from its cash reserve.

Expenditure

The operating expenditure for the year was £1.48m and it includes all costs including the direct cost of organising events and all costs related to the running of the office on a day-to-day basis including rent, and payroll. The expenditure for this year is higher than last year because of BACO 2023 expenditure.

ENTUK and its sub-groups spent £62k during the financial year to fund fellowships and strategic projects from the designated funds. The ENTUK Foundation awarded £35k as funding for educational, research and international fellowship grants. The British Rhinological Society awarded £9k in travelling fellowships and the Dragon Den Award, The British Society of Otology awarded £3k in smaller research grants to 3 individuals, the Global Health Committee awarded £8k to award three fellowships and published the Global Health Journal while Women in ENT Surgery spent £6k for mentor training and to run a social event at BACO 2023.

Summary and Financial Outlook

The total reported turnover for the year was £1.73m and the expenditure was £1.42m. Thus, the ENTUK Board of Trustees is pleased to report a small operational surplus of £316k, which is made up of £75k surplus from operating activities before BACO 2023, £194k surplus from designated activities including

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

51

fund transfer from BRS and £47k surplus from BACO2023 for the financial year 2022-23 before the revaluation gain on the investment portfolio.

Thus, the final reported accounting surplus for the financial year is £391k. The Board of Trustees of ENTUK have agreed to designate the £55k (£47k surplus from BACO2023 and an additional £8k receipt as funding for international fellowship from ENTUK Foundation) towards future BACO-related contingencies.

The total value of ENTUK’s charity funds (balance sheet) on the 30th of September 2023 was £3.38m compared to £3.00m in 2022.

Every year brings challenges for ENTUK, and the Executive Council and the Trustees are working hard to ensure ENTUK can remain on a sustainable path, whilst supporting ENT patients and clinicians in the UK and fulfilling its charitable aims. In a time of increased inflation, all members are looking at expenditure carefully, but their support of ENTUK remains as vital as ever to further ENT across our nation.

Reserves policy

What are Reserves

Reserves are that part of a charity’s unrestricted funds that are freely available to spend on any of the charity’s purposes. The starting point for calculating the reserves held is therefore the amount of unrestricted funds held by a charity. However, some or all of the unrestricted funds of a charity may not be readily available for spending. This is because spending those funds may adversely impact on the charity’s ability to deliver its aims. The items that should be excluded from reserves are:

Purpose

The purpose of the Reserves Policy for ENTUK is to ensure the stability of the mission, programmes, employment, and ongoing operations of the association and to provide a source of internal funds for organisational priorities.

The Reserves Policy will be implemented in line with the other governance and financial policies of ENTUK and is intended to support the goals and strategies contained in these related policies and in ENTUK’s strategic and operational plans.

There will be two Reserves:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

52

Operating Reserve

The operating reserve is to fund the day-to-day operational costs and any in-year actual or forecast deficit. The Operating Reserve is intended to provide an internal source of funds for situations such as covering the deficit from strategic lossmaking activities as agreed in the budget setting process, a sudden increase in expenses, one-time unbudgeted expenses, unanticipated loss in funding, or uninsured losses, including redundancies and material financial commitments.

The operating reserves are not intended to replace a permanent loss of funds or eliminate an ongoing budget gap.

The Operating Reserve fund is defined as a designated fund set aside by action of the Board of Trustees following a recommendation by the Finance Committee. The minimum amount to be designated as Operating Reserve will be established in an amount sufficient to maintain ongoing operations and programs measured for a set period of time, measured in annual cost.

The Operating Reserve serves a dynamic role and will be reviewed and adjusted in response to both internal and external environmental changes. The target current minimum Operating Reserve Fund will be calculated based on 12 month’s operating costs.

The calculation of average annual operating costs includes all recurring, predictable expenses such as staff salaries and benefits, occupancy, office, travel, program, and ongoing professional services.

Depreciation, benefit-in-kind, and other non-cash expenses are not included in the calculation. The calculation of average annual expenses also excludes ringfenced fund activities, capital expenses and partner payments.

The amount of the Operating Reserve Fund target minimum will be calculated each year after approval of the annual budget, reported to the Finance Committee/Board of Trustees, and included in the regular financial reports.

Opportunity Reserve

The opportunity to fund activities that help achieve the charity’s objectives but are not essential costs: The Opportunity Reserve is intended to provide funds to meet special targets of opportunity or need that further the objectives of ENTUK and which may or may not have a specific expectation of incremental or longterm increased income.

The Opportunity Reserve is also intended as a source of internal funds for organisational capacity building such as research and development, membership development, staff development, or investment in infrastructure that will build long-term capacity.

This reserve is intended to be set aside based on a 5-year time horizon of need and it is expected that it will be used, monitored and replenished frequently from the unrestricted reserve.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

53

Significant (large) legacies will be assigned to this reserve, so that their use can be ring-fenced for specific projects and ensure that they are not, so far as is possible, eaten up by general overheads.

The target amount of the Opportunity Reserve will be determined annually by the Board, based on a recommendation from the Finance Committee taking into account the following:

Accounting of Reserves

Designated/ring-fenced funds are excluded from the calculation of Reserves.

Reserves will be reported to Finance Committee on a quarterly basis.

Funding of Reserves

The Operating Reserve will be funded with surplus unrestricted operating funds.

The Board of Trustees may from time to time direct that a specific source of revenue be set aside for Operating Reserves. Examples could include one-time gifts or bequests, special grants, or special appeals.

The Opportunity Reserve will be funded with occasional special designations made by the Board of Trustees and significant legacies that have not been directed to the ENTUK Foundation.

Use of Reserves

1. Identification of appropriate use of Opportunity Reserve

2. Authority to use Opportunity Reserve Funds

3. Reporting and monitoring

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

54

Review of Policy

This Policy will be reviewed every year, at minimum, by the Finance Committee, or sooner if warranted by internal or external events or changes. Changes to the Policy will be recommended by the Finance Committee to the Board of Trustees.

Statement on Reserves

The total value of ENTUK’s balance sheet on 1[st] October 2023 was £3.4m up from £3.0m on 1[st] October 2022.

In 2021-2022, the Trustees of ENTUK revised the Reserves Policy. This policy revision was made to:

This process identified potential available funds, over and above those needed as an operational reserve. The Trustees voted to draw £50k per year from the investment portfolio, over five years beginning 2021-22, to create an Opportunity Reserve fund that should be used to support strategic projects.

The trustees of ENTUK have reviewed this policy during this financial year and have agreed to leave it unchanged. This policy will be reviewed periodically to ensure the level of reserves being maintained is at the optimum level.

Public Benefit

The Trustees confirm that they have complied with the requirements of section 17 of the Charities Act 2011 to have due regard to the Charity Commission's guidance on Public Benefit.

Major risk and management of those risks

The trustees have reviewed the major risks for the Association and have ensured adequate procedures have been established to manage those risks.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

55

Statement of Trustees’ responsibilities

The Trustees (who are also directors of ENTUK for the purposes of company law) are responsible for preparing the annual report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

The trustees’ annual report was approved on 4 March 2024 and signed on behalf of the board of trustees by:

Mr Andrew Swift Mr William Hellier President of ENTUK ENTUK Honorary Treasurer

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

56

ENTUK

formally known as ENT UK trading as British Academic Conference in Otolaryngology (BACO) and British Association of Otorhinolaryngology - Head and Neck Surgery (BAO-HNS)

(A company limited by guarantee)

Annual Report and Financial Statements for the Year Ended 30 September 2023

Reference and Administrative Details

Trustees

Secretary

Senior Management

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

57

Registered Office

38-43 Lincoln's Inn Fields London WC2A 3PE The charitable company is incorporated in England & Wales.

Charity number

1125524

Company Registration Number

6452601

Solicitors

SA Law 60 London Road St Albans Hertfordshire AL1 1NG

Bankers

NatWest Plc Bloomsbury Parr's PO Box 158 214 High Holborn London WC1V 7BX

Auditor

Edmund Carr LLP Chartered Accountants & Statutory Auditor 146 New London Road Chelmsford Essex CM2 0AW

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

58

Independent Auditor's Report to the Members of ENTUK

Opinion

We have audited the financial statements of ENTUK (the 'charitable company') for the year ended 30 September 2023, which comprise the Statement of Financial Activities, Statement of Cash Flows, and Notes to the Financial Statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

59

Other information

The other information comprises the information included in the trustees' report, other than the financial statements and our auditor’s report thereon. The trustees are responsible for the other information contained within the trustees' report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matter prescribed by the Companies

Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by

exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

60

companies’ exemptions in preparing the directors’ report and from the requirement to prepare a strategic report.

Other matters

The prior year financial statements were not required to be audited due to the total income being under the audit threshold. The accounts were instead subject to an independent examination.

Responsibilities of trustees

As explained more fully in the Statement of Trustees's Responsibilities, the trustees are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor responsibilities for the audit of the financial

statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows;

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

61

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur by:

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

As part of an audit in accordance with ISAs (UK), we exercise professional judgement and maintain professional scepticism throughout the audit. We also:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

62

----- Start of picture text -----
BACK TO THE
TABLE OF CONTENTS
----- End of picture text -----

We communicate with those charged with governance regarding the planned scope and timing of the audit and significant audit findings, including any deficiencies in internal control we identify during our audit.

Use of our report

This report is made solely to the charitable company's trustees, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's trustees those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its trustees as a body, for our audit work, for this report, or for the opinions we have formed.

Sandra Morrell FCCA (Senior Statutory Auditor)

For and on behalf of Edmund Carr LLP, Statutory Auditor

146 New London Road, Chelmsford, Essex, CM2 0AW

Date:.............................

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

63

Statement of Financial Activities for the Year

Ended 30 September 2023

(Including Income and Expenditure Account and Other Comprehensive Income)

Note Total 2023 Total 2022
£ £
Income from:
Charitable activities 3 1,654,392 673,205
Investment income 4 80,460 56,221
Total income 1,734,852 729,426
Expenditure on:
Raising funds 5 12,523 14,762
Charitable activities 6 1,405,529 690,619
Total expenditure 1,418,052 705,381
Net income before investment gains 316,800 24,045
Gains/losses on investment assets 74,678 (429,138)
Net income/(expenditure) 391,478 (405,093)
Net movement in funds 391,478 (405,093)
Reconciliation of funds
Total funds brought forward 2,993,234 3,398,327
Total funds carried forward 18 3,384,712 2,993,234

All of the charitable company's activities derive from continuing operations during the above two periods.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

64

Balance Sheet as at 30 September 2023

Note 2023
£		 2022
£
Fixed assets
Tangible assets 40,979 52,245
Investments 2,368,086 2,345,208
2,409,065 2,397,453
Current assets
Debtors 69,552 433,701
Cash at bank and in hand 1,087,601 592,366
1,157,153 1,026,067
Creditors: Amounts falling due within oneyear (181,506) (430,286)
Net currentassets 975,647 595,781
Netassets 3,384,712 2,993,234
Funds of the charitable company:
Unrestricted income funds
Unrestricted funds 3,384,712 2,993,234
Total funds 3,384,712 2,993,234

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The financial statements were approved by the trustees, and authorised for issue on 4 March 2024 and signed on their behalf by:

........................................

Mr William Hellier ENTUK Honorary Treasurer Trustee

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

65

Statement of Cash Flows

for the Year Ended 30 September 2023

Note 2023
£
2022
£
Cash flows from operating activities
Net movement in funds 391,478
(405,093)
Adjustments to cash flows from non-cash items
Depreciation
11		 12,638
7,086
Investment income
4		 (80,460)
(56,221)
Loss on disposal of investments -
10,014
Unrealisedgains/losses on investment assets
12		 (56,750)
419,124
266,906
(25,090)
Working capital adjustments
Decrease in stocks -
7,049
Decrease/(increase)in debtors
13		 364,149
(143,718)
Decrease in creditors
15		 (57,833)
(57,836)
(Decrease)/increase in deferred income (190,947)
207,064
Net cash flows from operatingactivities 382,275
(12,531)
Cash flows from investing activities
Interest receivable and similar income
4		 26,402
1,207
Purchase of tangible fixed assets
11		 (1,372)
(44,991)
Purchase of investments
12		 (258,226)
(220,884)
Sale of investments 292,098
287,490
Income from dividends
4		 54,058
55,014
Net cash flows from investingactivities 112,960
77,836
Net increase in cash and cash equivalents 495,235
65,305
Cash and cash equivalents at 1 October 592,366
527,061
Cash and cash equivalents at 30 September 1,087,601
592,366

All of the cash flows are derived from continuing operations during the above two periods.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

66

Notes to the Financial Statements

for the Year Ended 30 September 2023

1. Charitable company status

The charitable company is limited by guarantee, incorporated in England & Wales, and consequently does not have share capital. Each member is liable to contribute an amount not exceeding £1 towards the assets of the charitable company in the event of liquidation.

2. Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)) (issued in October 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

Basis of preparation

ENTUK meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.

Going concern

The trustees consider that there are no material uncertainties about the charitable company's ability to continue as a going concern nor any significant areas of uncertainty that affect the carrying value of assets held by the charitable company.

Income and endowments

Donations and legacies

General donations and other similar types of voluntary income are brought into account when receivable and donated income is included gross of any attributable tax recoverable, where relevant. Donations given for specific purposes are treated as restricted income.

Deferred income

Deferred income relates to conference attendance fees and exhibitor fees received for conferences due to take place after the year end.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

67

Investment income

Investment income is accounted for on a receivable basis once the dividend or interest has been declared.

Charitable activities

Subscriptions

Subscriptions are accounted for on a receivable basis, with the exception of life subscriptions that are recognised as income in full in the period in which they are received.

Other income

All other types of income are accounted for on an accruals basis.

Expenditure

All expenditure is recognised once there is a legal or constructive obligation to that expenditure, it is probable settlement is required and the amount can be measured reliably. All costs are allocated to the applicable expenditure heading that aggregate similar costs to that category. Where costs cannot be directly attributed to particular headings they have been allocated on a basis consistent with the use of resources, with central staff costs allocated on the basis of time spent, and depreciation charges allocated on the portion of the asset’s use. Other support costs are allocated based on the spread of staff costs.

All resources expended are inclusive of irrecoverable VAT.

Raising funds

These are costs incurred in attracting voluntary income, the management of investments and those incurred in trading activities that raise funds.

Charitable activities

Charitable expenditure comprises those costs incurred by the charitable company in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.

Grant expenditure

Grants payable are recognised in the period in which the approved offer is conveyed to the recipient except in those cases where the offer is conditional, such grants being recognised only when the conditions attaching to the award are fulfilled. Grants offered subject to conditions, which have not been met at the balance sheet date, are noted as a potential commitment, but are not treated as a liability.

Grant provisions

Provisions for grants are made when the intention to make a grant has been communicated to the recipient but there is uncertainty about either the timing of the grant or the amount of grant payable.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

68

Support costs

Support costs include central functions and have been allocated to activity cost categories on a basis consistent with the use of resources, for example, allocating property costs by floor areas, or per capita, staff costs by the time spent and other costs by their usage.

Taxation

The charitable company is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the charitable company is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

Tangible fixed assets

Individual fixed assets costing £1,000 or more are initially recorded at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation and amortisation

Depreciation is provided on tangible fixed assets so as to write off the cost or valuation, less any estimated residual value, over their expected useful economic life as follows:

----- Start of picture text -----
||| |---|---| |Asset class|Depreciation method and rate| |Office refurbishment|Over 5 years, straight-line| |Computers|Over 4 years, straight-line| |Office equipment|Over 5 years, straight-line|

----- End of picture text -----

Fixed asset investments

Fixed asset investments are included at market value at the balance sheet date. Realised gains and losses on investments are calculated as the difference between sales proceeds and their market value at the start of the year, or their subsequent cost, and are charged or credited to the Statement of Financial Activities in the period of disposal.

Unrealised gains and losses represent the movement in market values during the year and are credited or charged to the Statement of Financial Activities based on the market value at the year end.

Trade debtors

Trade debtors are amounts due from members and delegates for subscription and conference fees.

Trade debtors are recognised initially at the transaction price. A provision for the impairment of trade debtors is established when there is objective evidence that the Association will not be able to collect all amounts due according to the original terms of the receivables.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

69

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand, deposits and cash balances held by investment managers.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the Association does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised at the transaction price.

Fund structure

Unrestricted income funds are general funds that are available for use at the trustees' discretion in furtherance of the objectives of the Association. Designated funds are unrestricted funds set aside for specific purposes at the discretion of the trustees.

Pensions and other post retirement obligations

The charitable company participates in the Superannuation Arrangements of the University of London (SAUL), which is a centralised defined benefit scheme and is contracted-out of the Second State Pension. SAUL is a "last man standing" scheme so that in the event of the insolvency of any of the participating employers in SAUL, the amount of any pension funding shortfall (which cannot otherwise be recovered) in respect of that employer will be spread across the remaining participant employers and reflected in the next actuarial valuation. A formal valuation of SAUL is carried out every three years by professionally qualified and independent actuaries using the Projected Unit method. Informal reviews of SAUL's position are carried out between formal valuations.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

70

3. Income from charitable activities

Unrestricted funds
£		 Restricted funds
£		 Total 2023
£
Subscription income from members 484,309 - 484,309
Meetingand conference income 897,030 - 897,030
ENTUKproduct income 12,539 - 12,539
Marketingservices Income 8,300 - 8,300
Other income 252,214 - 252,214
1,654,392 - 1,654,392
Unrestricted funds
Restricted funds
Total 2022		 Unrestricted funds
Restricted funds
Total 2022
£
£
£
Subscription income from members 447,718
-
447,718
Meetingand conference income 109,605
-
109,605
ENTUKproduct income 22,280
-
22,280
Marketingservices Income 15,000
-
15,000
Other income 66,602
-
66,602
Consultancyincome 12,000
-
12,000
673,205
-
673,205

4. Investment income

Unrestricted funds Restricted funds Total 2023 Total 2022
£ £ £ £
Income from listed
investments		 54,058 - 54,058 55,014
Interest receivable on bank
deposits		 26,402 - 26,402 1,207
80,460 - 80,460 56,221

5. Expenditure on raising funds

Investment management costs

Note Unrestricted funds Restricted funds Total funds
£ £ £
Other investment management costs;
Investment management costs 12,523 - 12,523
Total for 2023 12,523 - 12,523
Total for 2022 14,762 - 14,762

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

71

6. Expenditure on charitable activities

Activity undertaken
directly
£		 Activity support 2023
£
costs
£
ClinotoJournal and other support costs 14,001 507,183 521,184
Conference costs 597,046 200,194 797,240
ENTUKproduct costs 7,613 - 7,613
Grants, bursaries and prizes awarded to
individuals		 13,272 13,272
-
Director of Education costs 7,595 - 7,595
Subscription to other relevant bodies 13,423 - 13,423
Donations 45,202 - 45,202
698,152 707,377 1,405,529
Activity undertaken
directly
£		 Activity support
costs
£		 2022
£
ClinotoJournal and other support costs 17,183 518,783 535,966
Conference costs 56,655 24,065 80,720
ENTUKproduct costs 9,648 - 9,648
Grants, bursaries and prizes awarded to
individuals		 12,900 - 12,900
Director of Education costs 7,015 - 7,015
Subscription to other relevant bodies 5,904 - 5,904
Donations 38,466 - 38,466
147,771 542,848 690,619

7. Analysis of support costs

Support costs allocated to charitable activities

Governance costs
£		 Administration costs
£		 Total 2023
£
Staff costs - 489,639 489,639
Travel and meetings expenses - 22,798 22,798
Website and other computer costs - 24,203 24,203
Advertisingand marketing - 5,665 5,665
Rent - 29,894 29,894
Other office costs - 24,973 24,973
Legal andprofessional fees - 62,650 62,650
Audit fees 8,491 - 8,491
Accountancyfees 4,865 - 4,865
Depreciation - 12,636 12,636
Bank and credit charges - 12,443 12,443
Sundryexpenses - 9,120 9,120
13,356 694,021 707,377

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

72

Governance costs
£		 Administration costs
£		 Total 2022
£
Staff costs - 330,518 330,518
Travel and meetings expenses - 8,422 8,422
Website and other computer costs - 46,607 46,607
Advertisingand marketing - 6,018 6,018
Rent - 21,834 21,834
Other office costs - 32,749 32,749
Legal andprofessional fees - 75,058 75,058
Independent examination fees 4,000 - 4,000
Accountancyfees 4,633 - 4,633
Depreciation - 7,086 7,086
Bank and credit charges - 6,474 6,474
Sundryexpenses - (551) (551)
8,633 534,215 542,848

8. Net incoming/outgoing resources

Net incoming resources for the year include:

2023
£		 2022
£
Operatingleases - other assets 30,511 30,511
Loss on disposal of investments - 10,014
Depreciation of fixed assets 12,636 7,086

9. Trustees remuneration and expenses

No trustees, nor any persons connected with them, have received any remuneration from the charitable company during the year.

During the year, 4 Trustees (2022: 4) were reimbursed for reasonable travel and meetings expenses amounting to £3,795 (2022: £1,701).

10. Staff costs

The aggregate payroll costs were as follows:

2023 2022
£ £
Staff costs during the year were:
Wages and salaries 395,307 247,628
Social security costs 29,975 30,562
Pension costs 64,357 52,328
489,639 330,518

The increase in wages and salaries is due to prepaid staff costs brought forward from the prior year that relate to the BACO 23 conference that took place in 2023.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

73

The monthly average number of persons (including senior management team) employed by the charitable company during the year expressed by head count was as follows:

was as follows:
2023 2022
No No
Administration 8 8

The number of employees whose emoluments fell within the following bands was:

2023
No
2022
No
£70,001 - £80,000 1
-

The total employee benefits of the key management personnel of the charitable company were £97,993 (2022 - £94,737).

11. Tangible fixed assets

Computers and office equipment
£		 Total
£
Cost
At 1 October 2022 204,561 204,561
Additions 1,372 1,372
At 30 September 2023 205,933 205,933
Depreciation
At 1 October 2022 152,316 152,316
Charge for theyear 12,638 12,638
At 30 September 2023 164,954 164,954
Net book value
At 30 September 2023 40,979 40,979
At 30 September 2022 52,245 52,245

12. Fixed asset investments

Listed investments

12. Fixed asset investments
Listed investments
Listed investments
£
Cost or Valuation
At 1 October 2022 2,345,208
Revaluation 56,750
Additions 258,226
Disposals (292,098)
At 30 September 2023 2,368,086
Net book value
At 30 September 2023 2,368,086
At 30 September 2022 2,345,208

At the balance sheet date, the historical cost of the investments was £2,104,876 (2022: £2,110,170).

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

74

13. Debtors

13. Debtors
2023
£		 2022
£
Trade debtors 46,737 56,205
Prepayments 21,622 322,380
Other debtors 1,193 55,116
69,552 433,701

14. Cash and cash equivalents

2023
£		 2022
£
Cash at bank 1,087,601 592,366

15. Creditors: amounts falling due within one year

2023
£		 2022
£
Trade creditors 33,250 22,472
Other taxation and social security 9,552 24,611
Other creditors 42,468 39,509
Pension scheme creditor 6,973 6,569
Accruals 50,842 107,757
Deferred income 38,421 229,368
181,506 430,286
2023
£
Deferred income at 1 October 2022 229,368
Resources deferred in theperiod 38,421
Amounts released frompreviousperiods (229,368)
Deferred income at 30 September 2023 38,421

16. Obligations under leases and hire purchase contracts

Operating lease commitments

Total future minimum lease payments under non-cancellable operating leases are as follows:

2023
£		 2022
£
Within oneyear
33,420		 30,511
Between one and fiveyears
50,130		 76,278
83,550 106,789

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

75

17. Pension and other schemes

Defined benefit pension schemes

Superannuation Arrangements of the University of London (SAUL)

The charitable company participates in the Superannuation Arrangements of the University of London (SAUL), which is a centralised defined benefit scheme and is contracted-out of the Second State Pension for all eligible employees with the assets held in separate Trustee administered funds.

The charitable company has adopted FRS 102 for accounting for pension costs. It is not possible to identify the Charity's share of the underlying assets and liabilities of SAUL. Therefore contributions are accounted for as if SAUL were a defined contribution scheme and pension costs are based on the amounts actually paid (i.e. cash amounts) in accordance with FRS 102. SAUL is subject to triennial valuations by professionally qualified and independent actuaries.

The last available valuation was carried out as at 31 March 2020 using the projected unit credit method in which the actuarial liability makes allowance for projected earnings.

The main assumptions used to assess the technical provisions were:

As a whole, the market value of the scheme's assets was £3.612 million (31/03/2017: £3.204 million) representing 94% (31/03/2017: 102%) of the liability for benefits after allowing for expected future increases in salaries. The Trustee and the employers agreed to increase employer contributions to 21% of salaries from 19% as of 1 January 2023. Member contributions are set at 6% of salaries.

The total cost relating to defined benefit schemes for the year recognised in profit or loss as an expense was £64,357 (2022 - £52,328).

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

76

18. Funds

18. Funds
Balance at 1
October 2022
£		 Incoming
resources
£		 Resources
expended
£		 Gains, losses
and transfers
£		 Balance at 30
September 2023
£
Unrestrictedfunds
General fund 2,835,787 1,489,706 (1,356,441) (32,173) 2,936,879
Designatedfunds
ENTUK Foundation 69,088 56,357 (34,600) (15,231) 75,614
BOARS Fund 19,781 - - (1,500) 18,281
BSO Fund 30,027 - (3,255) 6,438 33,210
Global Health
Committee		 10,547 3,400 (7,974) 126 6,099
Women in ENT
Surgery		 4,264 2,250 (6,030) 3,847 4,331
ENTUK drawing
account		 23,740 - - 45,383 69,123
BACO - - - 54,684 54,684
Historyof ENT - 2,582 (658) - 1,924
Head and Neck
society		 - - - 8,284 8,284
BRS - 178,557 (8,869) 2,812 172,500
SFO - - (225) 950 725
British Society of
Facial Plastics
Surgery		 - 2,000 - 1,058 3,058
157,447 245,146 (61,611) 106,851 447,833
Total funds 2,993,234 1,734,852 (1,418,052) 74,678 3,384,712

The specific purposes for which the funds are to be applied are as follows:

The ENTUK Foundation fund comprises various funds donated to the charity and designated by the Trustees to be used for various fellowship awards.

The BOARS fund started when the Otorhinolaryngological Research Society transferred £15,000 to ENTUK on transferring its activities to the charity.

The ENTUK drawing account consists of transfers in for the proceeds of the sale of investments to be used for future fellowship awards.

BSO funds are designated funds to be used for the sole benefit of Otology section of ENTUK.

BRS funds are designated funds to be used by BRS for Rhinology activities. Comparative information in respect of the preceding period is as follows:

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

77

Balance at 1
October 2021
£		 Incoming
resources
£		 Resources
expended
£		 Gains, losses
and transfers
£		 Balance at 30
September 2022
£
Unrestricted
funds
General fund 3,310,729 656,337 (643,671) (487,608) 2,835,787
Designated
funds
ENTUK
Foundation		 35,314 60,300 (26,526) - 69,088
BOARS Fund 11,016 9,189 (424) - 19,781
BSO Fund 31,846 - (5,000) 3,181 30,027
Global Health
Committee		 8,258 - (3,000) 5,289 10,547
Women in ENT
Surgery		 1,164 3,600 (500) - 4,264
ENTUK drawing
account		 - - (26,260) 50,000 23,740
87,598 73,089 (61,710) 58,470 157,447
Total funds 3,398,327 729,426 (705,381) (429,138) 2,993,234

19. Analysis of net assets between funds


Restricted funds
£		 Total funds at
30 September 2023
£
Unrestricted funds
£
Tangible fixed assets 40,979
-		 40,979
Fixed asset investments 2,368,086
-		 2,368,086
Current assets 1,157,153
-		 1,157,153
Current liabilities (181,506) - (181,506)
Total net assets 3,384,712
-		 3,384,712

Prior year:

Unrestricted funds Restricted funds
£		 Total funds 2022
£
£
Tangible fixed assets 52,245 - 52,245
Fixed asset investments 2,345,208 - 2,345,208
Current assets 1,026,067 - 1,026,067
Current liabilities (430,286) - (430,286)
Total net assets 2,993,234 - 2,993,234

20. Related party transactions

There were no related party transactions in the year.

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

78

21. Agency arrangements

The charitable company holds funds on behalf of the Student Bootcamp, a third party. In the accounting period ending 30 September 2023 the academy trust received £19,700 (2022: £36,950) and disbursed £15,617 (2022: £11,000) from the fund. An amount of £42,468 (2022: £38,385) is included in other creditors relating to undistributed funds that is repayable to the Student Bootcamp.

22. Prior year Statement of Financial Activities

Note Unrestricted
£		 Restricted
£		 Total 2022
£
Income and Endowments from:
Charitable activities
3		 673,205 - 673,205
Investment income
4		 56,221 - 56,221
Total income 729,426 - 729,426
Expenditure on:
Raisingfunds
5		 14,762 - 14,762
Charitable activities
6		 690,619 - 690,619
Total expenditure 705,381 - 705,381
Gains/losses on investment assets (429,138) - (429,138)
Net expenditure (405,093) - (405,093)
Net movement in funds (405,093) - (405,093)
Reconciliation of funds
Total funds brought forward 3,398,327 - 3,398,327
Total funds carried forward
18		 2,993,234 - 2,993,234

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

79

Principal Office The Royal College of Surgeons 38-43 Lincoln's Inn Fields, London, WC2A 3PE The charity is incorporated in England and Wales

Company Registration Number 6452601

Charity Registration Number 1125524

VAT No 215668302

Solicitors

SA Law

60 London Road, St Albans, Hertfordshire, AL1 1NG

Bankers

National Westminster Bank Plc

Bloomsbury Parr's, PO Box 158, 214 High Holborn, London, WC1V 7BX

Auditor

Edmund Carr LLP

Chartered Accountants & Statutory Auditor 146 New London Road, Chelmsford, Essex, CM2 0AW

Investment fund managers

Brewin Dolphin Limited

12 Smithfield Street, London, EC1A 9BD

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 80 |

AAO-HNS American Academyof Otolaryngology-Head and Neck Surgery
AOMRC Academyof Medical Royal Colleges
AOT Association of Otolaryngologists in Training
ASGBI Association of Surgeons of Great Britain and Ireland
ASiT Association of Surgeons in Training
BACO British Academic Conference of Otolaryngology
BAETS British Association of Thyroid and Endocrine Surgeons
BAOMS British Association or Oral and Maxillofacial Surgeons
BAPO British Association of Paediatric Otorhinolaryngologists
BAPRAS British Association of Plastic Reconstructive and Aesthetic Surgeons
BAPS British Association of Paediatric Surgeons
BLA British Laryngological Association
BOARS The British Otorhinolaryngologyand Allied Sciences Research Society
BRS British Societyof Rhinology
BSACI British Societyfor Allergyand Clinical Immunology
BSHENT British Societyfor the Historyof ENT
BSFPS The British Societyof Facial Plastic Surgery
BSO The British Societyof Otology
BTA British Thyroid Association
BVA British Voice Association
e-lefENT E-learning platform
EAFPS The European Academyof Facial Plastic Surgery
ENT Common abbreviation for ear, nose and throat
ERS European Rhinological Society
ESPO The European Societyof Paediatric Otorhinolaryngology
FPS UK Former name of The British Societyof Facial Plastic Surgery(BSFPS)
FSSA Federation of Surgical SpecialtyAssociations
GMC General Medical Council
HNSoc Head and Neck Society
IOS Irish Otorhinolaryngology/Head & Neck SurgerySociety
IPC Independent Practice Committee
MTI Medical TrainingInitiative
NICE National Institute for Health and Care Excellence
RCGP Royal College of General Practitioners
RCN Royal College of Nursing
RCPSG Royal College of Physicians and Surgeons of Glasgow
RCSEd Royal College of Surgeons of Edinburgh
RCSEng Royal College of Surgeons of England
RCSI Royal College of Surgeons of Ireland
RSM Royal Societyof Medicine
SAC Special AdvisoryCommittee
SAS Staff and Associate Specialists (i.e. the ENT Staff and Associate Specialist
Doctors’ Groupof the Education and TrainingCommittee)
SFO UK Student and Foundation Doctors in Otolaryngology
TWJ Foundation Thomas Wickham Jones Foundation
WENTS UK Women in ENT Surgery
YCOHNS YoungConsultants in OtolaryngologyHead and Neck Surgery

BACK TO THE TABLE OF CONTENTS

ENTUK Company registration number: 06452601 Charitable company registration number: 1125524

ANNUAL REPORT 2022 - 2023 |

81